Zimmer Biomet Holdings, Inc. logo

Zimmer Biomet Holdings, Inc. (ZBH)

Market Open
3 Mar, 16:38
NYSE NYSE
$
97. 09
-2.4
-2.41%
$
19.51B Market Cap
24.97 P/E Ratio
0.96% Div Yield
0 Volume
8.06 Eps
$ 99.49
Previous Close
Day Range
96.3 98.03
Year Range
84.59 114.44
Want to track ZBH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
ZBH earnings report is expected in 62 days (4 May 2026)
Zimmer Biomet Holdings, Inc. (ZBH) Q4 2025 Earnings Call Transcript

Zimmer Biomet Holdings, Inc. (ZBH) Q4 2025 Earnings Call Transcript

Zimmer Biomet Holdings, Inc. (ZBH) Q4 2025 Earnings Call Transcript

Seekingalpha | 2 weeks ago
ZBH Q4 Earnings & Revenues Top Estimates, Stock Up in Pre-Market

ZBH Q4 Earnings & Revenues Top Estimates, Stock Up in Pre-Market

Zimmer Biomet beats Q4 earnings and revenue estimates, with sales up 10.9% and shares rising 1.4% pre-market despite margin contraction.

Zacks | 2 weeks ago
Zimmer (ZBH) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Zimmer (ZBH) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for Zimmer (ZBH) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks | 3 weeks ago
Zimmer Biomet (ZBH) Q4 Earnings and Revenues Top Estimates

Zimmer Biomet (ZBH) Q4 Earnings and Revenues Top Estimates

Zimmer Biomet (ZBH) came out with quarterly earnings of $2.42 per share, beating the Zacks Consensus Estimate of $2.38 per share. This compares to earnings of $2.31 per share a year ago.

Zacks | 3 weeks ago
Unveiling Zimmer (ZBH) Q4 Outlook: Wall Street Estimates for Key Metrics

Unveiling Zimmer (ZBH) Q4 Outlook: Wall Street Estimates for Key Metrics

Evaluate the expected performance of Zimmer (ZBH) for the quarter ended December 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Zacks | 3 weeks ago
Zimmer Biomet to Report Q4 Earnings: Here's What to Expect

Zimmer Biomet to Report Q4 Earnings: Here's What to Expect

ZBH is set to report Q4 on Feb. 10, with revenues seen at $2.20B and EPS at $2.38 as hips, knees, robotics and S.E.T. drive growth estimates.

Zacks | 3 weeks ago
Zimmer Biomet (ZBH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Zimmer Biomet (ZBH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Zimmer (ZBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks | 4 weeks ago
Here's Why Zimmer Biomet (ZBH) is a Strong Value Stock

Here's Why Zimmer Biomet (ZBH) is a Strong Value Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 1 month ago
How the OneStep Partnership Could Drive Growth for ZBH Stock

How the OneStep Partnership Could Drive Growth for ZBH Stock

Zimmer Biomet teams up with OneStep to integrate mobility analytics into mymobility, empowering surgeons and patients while advancing its connected care strategy.

Zacks | 2 months ago
Why Is Zimmer (ZBH) Up 5.3% Since Last Earnings Report?

Why Is Zimmer (ZBH) Up 5.3% Since Last Earnings Report?

Zimmer (ZBH) reported earnings 30 days ago. What's next for the stock?

Zacks | 2 months ago
Here's Why Zimmer Biomet (ZBH) is a Strong Value Stock

Here's Why Zimmer Biomet (ZBH) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 3 months ago
Zimmer Biomet Holdings, Inc. (ZBH) Presents at Jefferies London Healthcare Conference 2025 Transcript

Zimmer Biomet Holdings, Inc. (ZBH) Presents at Jefferies London Healthcare Conference 2025 Transcript

Zimmer Biomet Holdings, Inc. ( ZBH ) Jefferies London Healthcare Conference 2025 November 18, 2025 7:00 AM EST Company Participants Ivan Tornos - President, CEO & Chairman of the Board Suketu Upadhyay - CFO and Executive VP of Finance, Operations & Supply Chain Conference Call Participants Matthew Taylor - Jefferies LLC, Research Division Presentation Matthew Taylor Jefferies LLC, Research Division All right. Great. Thanks for joining us for our next session here at the Jefferies Healthcare Conference.

Seekingalpha | 3 months ago
Loading...
Load More